Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-13-000033

Director disposed of 13,367,481 shares (other)

  • Director returned 523,926 shares (to the company)
  • Director acquired 8,230,453 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

NARINE JEENARINE · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2013-04-25 Returned to the company : show line 1 in the form −150,000 $0.08 $12,000 16,412,461 I
2013-04-26 Returned to the company : show line 2 in the form −243,926 $0.08 $19,563 16,168,535 I
2013-04-26 Conversion : show line 3 in the form +8,230,453 24,398,988 I
2013-04-29 Returned to the company : show line 4 in the form −130,000 $0.08 $10,400 24,268,988 I
2013-04-29 Other disposition : show line 5 in the form −13,367,481 $0.04 $493,260 15,357,334 I

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2013-04-26 Conversion : show line 6 in the form Series E Convertible Preferred Stock −200 $1,000.00 $200,000 1,600 I
2013-04-26 Other disposition : show line 7 in the form Warrants −13,272,999 26,727,001 I
Loading xslF345X03/primary_doc.xml…